Trials / Completed
CompletedNCT04573725
Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, randomized, placebo-controlled, 4-arm, 4-period crossover double-blind comparative study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-142 | Participants received single-dose of 5, 10, 30 mg of TS-142 (oral capsule) |
| DRUG | Dose-matched Placebo to TS-142 | Participants received single dose-matched placebo to TS-142 (oral capsule) |
Timeline
- Start date
- 2017-07-07
- Primary completion
- 2019-02-13
- Completion
- 2019-02-13
- First posted
- 2020-10-05
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04573725. Inclusion in this directory is not an endorsement.